课题基金 / 基金详情

Mechanisms of Ocular Immune Privilege in the Posterior Eye

Mechanisms of Ocular Immune Privilege in the Posterior Eye
后眼的眼部免疫特权机制
批准号:
8047973
负责人:
Joan Stein-Streilein
金额:
$23.31万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2013-03-31

项目摘要

项目成果

Joan Stein-Streilein的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Immune privilege is conserved in all species as a mechanism to provide immunoprotection for organs and tissues. Immune privilege allows for immune protection in the absence of inflammation. When immune privilege is compromised, the eye is at risk for immune inflammatory and autoimmune diseases such as uveitis. Immune privilege is a multi-layered process and even during experiment autoimmune uveitis, immune privilege is only transiently lost, and returns to prevent a reoccurrence of the disease (1). However, our studies show that retinal laser burn (RLB) in one eye caused an extended loss of ocular immune privilege in both the laser treated and non-treated eye (2). In this R21 project we would like to exploit these observations and analyze the mechanisms that led to the abrogation of immune privilege. We propose that RLB abrogates immune privilege by inducing changes to the retinal- pigmented epithelium (RPE) and its suppressor function which in turn leads to increased susceptibility to experimental autoimmune uveitis (EAU). Our research plan will 1.) Analyze how and what RPE suppression function is lost; 2.) Compare changes in the expression of candidate regulatory molecules on RPE that might change during or after RLB; 3.) Determine if there is increased susceptibility to autoimmune uveitis in mice after RLB. PUBLIC HEALTH RELEVANCE: This R21 application will determine (using state of the art cellular, molecular approaches) how experimental retinal laser burn abrogates immune privilege in the posterior eye. The knowledge gained from these studies will enhance our understanding of ocular immune homeostasis and may aid in the development of new therapies for restoration of the immune privileged status in eyes that suffer from trauma or inflammatory diseases such as autoimmune uveitis.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3109/08830185.2012.740535
发表时间: 2013
期刊: International reviews of immunology
影响因子: 5
作者: [Stein-Streilein,Joan]
通讯作者: Stein-Streilein,Joan
Mechanisms of Ocular Immune Privilege in the Posterior Eye
  • 批准号:
    7872399
  • 项目类别:
  • 资助金额:
    $29.29万
  • 财政年份:
    2010
  • 负责人:
    Joan Stein-Streilein
  • 依托单位:
Adaptive and innate regulation of immuneprivilege
  • 批准号:
    7388130
  • 项目类别:
  • 资助金额:
    $56.12万
  • 财政年份:
    2006
  • 负责人:
    Joan Stein-Streilein
  • 依托单位:
Adaptive and innate regulation of immuneprivilege
  • 批准号:
    7195014
  • 项目类别:
  • 资助金额:
    $48.73万
  • 财政年份:
    2006
  • 负责人:
    Joan Stein-Streilein
  • 依托单位:
Adaptive and innate regulation of immune privilege
  • 批准号:
    7618420
  • 项目类别:
  • 资助金额:
    $58.28万
  • 财政年份:
    2006
  • 负责人:
    Joan Stein-Streilein
  • 依托单位:
海外基金